Biomarker: F309-IgE Chick Pea
Overview
Chickpea, or Cicer arietinum, is a legume consumed as whole seeds, flour, and processed foods. It is a food allergen associated with IgE-mediated sensitization and reactions that may include respiratory symptoms, urticaria, gastrointestinal symptoms, or anaphylaxis. Exposure usually occurs through ingestion, although inhalation of chickpea flour or occupational contact may also be relevant. Serum-specific IgE testing can help evaluate suspected chickpea sensitization, but a positive result indicates sensitization and does not independently establish clinical allergy.
Clinical Use Cases
Evaluation of suspected IgE-mediated food allergy: Serum-specific IgE to chickpea may support evaluation when symptoms occur reproducibly after chickpea ingestion.
Investigation of exposure-related symptoms: Testing may be considered for immediate symptoms such as urticaria, angioedema, wheezing, rhinitis, vomiting, or anaphylaxis after eating chickpea or foods containing chickpea flour.
Serum allergen-specific IgE assessment: Measurement of chickpea-specific IgE in blood can identify immunologic sensitization to chickpea proteins.
Integration with clinical history: Results should be interpreted with the timing, reproducibility, amount and preparation of chickpea consumed, symptoms, and relevant co-factors.
Assessment of related legume sensitization: Testing may be performed alongside evaluation for lentil, pea, peanut, soybean, or other legumes when the clinical history suggests a broader legume-sensitization pattern.
Confirmation when uncertainty remains: A medically supervised oral food challenge may be considered when history and allergy testing do not establish whether chickpea causes clinical reactions.
Measurement Methods
Allergen-specific IgE testing: In-vitro immunoassays measure IgE antibodies in serum directed against chickpea extract or chickpea proteins. The result identifies sensitization and must be interpreted with clinical findings.
Component-resolved diagnostics: Testing for IgE directed against individual chickpea allergenic proteins may provide more specific information when clinically available. Reported chickpea components include proteins in the vicilin, 2S albumin, lipid-transfer-protein, and 11S globulin families, although component testing is less established for chickpea than for some major food allergens.
Immunoblot or inhibition studies: Human research has used immunoblotting and inhibition assays to characterize chickpea-reactive IgE and investigate cross-reactivity, but these are primarily research methods rather than routine clinical tests.
Skin-prick testing: May be used as an adjunct to serum testing during allergy evaluation, but it measures sensitization and does not independently confirm clinical allergy.
Oral food challenge: A supervised challenge can assess clinical reactivity when the diagnosis remains uncertain. It is not a laboratory measurement and should be performed only in an appropriate medical setting.
Test Preparation and Influencing Factors
Medications: Serum-specific IgE testing generally does not require stopping antihistamines because the assay measures circulating antibodies rather than skin reactivity.
Fasting: Fasting is generally not required for serum-specific IgE testing unless other tests collected during the same blood draw require it.
Food avoidance: Avoiding chickpea before blood collection does not reliably eliminate detectable chickpea-specific IgE. Avoidance decisions should be made with clinical guidance.
Timing after exposure: A recent reaction may help guide testing, but the clinical history remains essential. A negative result does not exclude allergy in every circumstance, particularly if relevant allergenic components are not represented in the assay.
Total IgE concentration: Total serum IgE should not be used alone to diagnose chickpea allergy. Very high total IgE may complicate interpretation of some specific-IgE results.
Age: IgE concentrations and the likelihood of food allergy vary with age. Results should be interpreted using age-appropriate clinical context rather than a single universal threshold.
Cross-reactive sensitization: IgE binding to chickpea may reflect sensitization to related legumes, including lentil or pea, rather than clinically relevant chickpea allergy in every patient.
Clinical history: A positive test demonstrates sensitization, not necessarily symptomatic allergy. Symptom timing, reproducibility, food dose, preparation, and co-factors are important for interpretation.
Test concentration and severity: The amount of chickpea-specific IgE may influence the probability of reactivity in a given population, but it does not reliably predict reaction severity.
Cross-Reactivity
Lentil and pea: Human clinical and immunologic studies report an association between chickpea allergy and lentil or pea allergy. Inhibition studies indicate that pea and lentil proteins can suppress IgE binding to chickpea globulin proteins.
Soybean and hazelnut: IgE cross-reactivity has been demonstrated between chickpea and soybean or hazelnut protein extracts in human serum studies. These findings show immunologic recognition and do not establish that every sensitized person will react clinically to each food.
Seed-storage proteins: Vicilin and other globulin proteins, including 7S and 11S storage-protein families, are considered important contributors to cross-reactive IgE binding among legumes.
Peanut and related legumes: Homologous storage proteins may contribute to IgE recognition between chickpea and peanut or other legumes. Co-sensitization is variable and depends on the individual and regional dietary patterns.
Clinical relevance: Cross-reactive IgE can produce a positive chickpea-specific IgE result without clinically meaningful chickpea allergy. Results should be interpreted alongside symptoms after chickpea exposure and, when necessary, a supervised oral food challenge.
Synonyms
Common name: Chickpea
Alternative common names: Garbanzo bean, Bengal gram, gram, chana, ceci bean
Scientific name:Cicer arietinum
Allergen designation: F309, chickpea
This information is provided for general educational purposes and is not medical advice. Biomarker information may describe testing methods, measurements, or interpretations that vary by laboratory or specific test. For details about a particular lab test, including biomarkers measured, specimen type, collection requirements, preparation, and turnaround time, please refer to the individual test description. Talk with a licensed health care provider about your results.
